DOK1/PPARgamma pathway mediates anti-tumor ability of all-trans retinoic acid in breast cancer MCF-7 cells
Authors:
- 1 May 2017
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 487 (2) , 189-193
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Unlocking the potential of retinoic acid in anticancer therapyBritish Journal of Cancer, 2014
- Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemiaInternational Journal of Cancer, 2014
- Retinoids and breast cancer: From basic studies to the clinic and back againCancer Treatment Reviews, 2014
- Retinoid receptor signaling and autophagy in acute promyelocytic leukemiaExperimental Cell Research, 2014
- mRNA expression of DOK1-6 in human breast cancerWorld Journal of Clinical Oncology, 2014
- Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in gliaMolecular and Cellular Neuroscience, 2013
- Transcriptional Regulation of the Human Tumor Suppressor DOK1 by E2F1Molecular and Cellular Biology, 2012
- Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancerMolecular Oncology, 2011
- Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcomaLaboratory Investigation, 2010
- Identification of DOK genes as lung tumor suppressorsNature Genetics, 2010